Dudediligence.

Capricor Therapeutics, Inc

CAPRNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

58.1M

on 2026-06-30, from 31.6M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

20M40M60MMar2024JunSepDecMar2025JunSepDec$25.00Mar2026Jun

Newest

$300.0M

S-3 of 2025-09-10. 1 prospectus supplement filed under it since. S-3 ↗

$150.0M

Capricor Therapeutics, agreement of 2025-09-10. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗

Warrants

3.35M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

9.2 quarters

$237.9M on 2026-06-30 ÷ $26.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-12-05Public offering6,000,000$25.00$150.0M424B5 ↗